• 277 Citations
  • 10 h-Index
20042016
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Federica Gigli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
Azacitidine Medicine & Life Sciences
Comorbidity Medicine & Life Sciences
Survival Medicine & Life Sciences
Graft vs Host Disease Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Cytogenetics Medicine & Life Sciences
Photopheresis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2016

  • 277 Citations
  • 10 h-Index
  • 24 Article

Plasma endocannabinoid behaviour in total knee and hip arthroplasty

Ottria, R., Cappelletti, L., Ravelli, A., Mariotti, M., Gigli, F., Romagnoli, S., Ciuffreda, P., Banfi, G. & Drago, L., Oct 2016, In : Journal of Biological Regulators and Homeostatic Agents. 30, 4, p. 1147-1152 6 p.

Research output: Contribution to journalArticle

Endocannabinoids
Knee Replacement Arthroplasties
Hip
Pain Perception
Blood Sedimentation

The influence of disease and comorbidity risk assessments on the survival of MDS and oligoblastic AML patients treated with 5-azacitidine: A retrospective analysis in ten centers of the "Rete Ematologica Lombarda"

Molteni, A., Riva, M., Borin, L., Bernardi, M., Pelizzari, A. M., Freyrie, A., Della Porta, M. G., Nichelatti, M., Ravano, E., Quaresmini, G., Mariotti, J., Caramazza, D., Ubezio, M., Guarco, S., Gigli, F., Greco, R., Cairoli, R. & Morra, E., Mar 1 2016, In : Leukemia Research. 42, p. 21-27 7 p.

Research output: Contribution to journalArticle

Azacitidine
Comorbidity
Survival
Cytogenetics
Therapeutics
5 Citations (Scopus)

The influence of disease and comorbidity risk assessments on the survival of MDS and oligoblastic AML patients treated with 5-azacitidine: A retrospective analysis in ten centers of the "Rete Ematologica Lombarda"

Molteni, A., Riva, M., Borin, L., Bernardi, M., Pelizzari, A. M., Freyrie, A., Porta, M. D., Nichelatti, M., Ravano, E., Quaresmini, G., Mariotti, J., Caramazza, D., Ubezio, M., Guarco, S., Gigli, F., Greco, R., Cairoli, R. & Morra, E., Mar 1 2016, In : Leukemia Research. 42, p. 21-27 7 p.

Research output: Contribution to journalArticle

Azacitidine
Comorbidity
Survival
Cytogenetics
Therapeutics

The influence of disease and comorbidity risk assessments on the survival of MDS and oligoblastic AML patients treated with 5-azacitidine: A retrospective analysis in ten centers of the "Rete Ematologica Lombarda"

Molteni, A., Riva, M., Borin, L., Bernardi, M., Pelizzari, A. M., Freyrie, A., Della Porta, M. G., Nichelatti, M., Ravano, E., Quaresmini, G., Mariotti, J., Caramazza, D., Ubezio, M., Guarco, S., Gigli, F., Greco, R., Cairoli, R. & Morra, E., Mar 1 2016, In : Leukemia Research. 42, p. 21-27 7 p.

Research output: Contribution to journalArticle

Azacitidine
Comorbidity
Survival
Cytogenetics
Therapeutics

The influence of disease and comorbidity risk assessments on the survival of MDS and oligoblastic AML patients treated with 5-azacitidine: A retrospective analysis in ten centers of the "Rete Ematologica Lombarda"

Molteni, A., Riva, M., Borin, L., Bernardi, M., Pelizzari, A. M., Freyrie, A., Della Porta, M. G., Nichelatti, M., Ravano, E., Quaresmini, G., Mariotti, J., Caramazza, D., Ubezio, M., Guarco, S., Gigli, F., Greco, R., Cairoli, R. & Morra, E., Mar 1 2016, In : Leukemia Research. 42, p. 21-27 7 p.

Research output: Contribution to journalArticle

Azacitidine
Comorbidity
Survival
Cytogenetics
Therapeutics